Drug eluting Stent for Vascular Intervention
- UID
- IMP/MD/2020/000232_29ce6a3f9882e11b6805913c5b1f048d_1e0b30c4c53fae0362b193132d5b54fa
- Device class
- Class D
- Brand name
- Pantera
- License holder
- Biotronik Medical Devices India Pvt Ltd.
- Approving authority
- CDSCO
- Product information
- Orsiro Mission is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heartdisease due to discrete de-novo stenotic lesions and in-stent restenotic lesions (Pantera) in the native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm including the following patient and lesion subsets: • Acute Coronary Syndrome (Pantera) • ST-Elevation Myocardial Infarction (Pantera) • Diabetes Mellitus (Pantera) • Complex Lesions (Pantera) • High Bleeding Risk (Pantera) • Long Lesions (Pantera) (Pantera) • Small Vessels (Pantera) (Pantera) • Multi-Vessel Disease (Pantera) • Male/Female • Old Patients (Pantera)
Drug eluting Stent for Vascular Intervention is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000232_29ce6a3f9882e11b6805913c5b1f048d_1e0b30c4c53fae0362b193132d5b54fa. This device is marketed under the brand name Pantera. The license holder is Biotronik Medical Devices India Pvt Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.